Clinical laboratory tests play a crucial role in making sure patients get appropriate care, yet many small labs and clinics in low resource settings cannot afford the instruments needed to provide these tests. Research on a novel fingerprick test that can perform all common clinical diagnostics could help to expand access to basic medical testing in the developing world, and will be featured at the 2015 AACC Annual Meeting & Clinical Lab Expo.
Public health experts estimate that approximately one third of the world’s population does not have adequate access to quality healthcare due to a range of barriers, from limited geographic accessibility to a lack of affordable services. Clinical laboratories in particular are poorly outfitted and sparsely distributed in low-income countries, and few primary healthcare centers in these regions are located within reach of a well-equipped and staffed lab. So-called point-of-care testing devices that are portable and do not require lab support could improve access to testing in underserved areas. However, multiple point-of-care instruments would be required to run the full spectrum of common clinical tests, and this equipment is often expensive.
At AACC’s 2015 Annual Meeting, researchers from DiaSys Diagnostics India in Mumbai will present the first point-of-care device, named QDx InstaLab, that can perform all of the clinical tests that labs routinely order as part of yearly physicals to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Additionally, the QDx InstaLab can test cholesterol levels to screen for risk of heart disease or to monitor treatment for it, and can screen for bleeding problems or monitor treatment for inappropriate blood clotting as well. To run these numerous tests, the device analyzes a few drops of blood from a fingerprick using inexpensive microfluidic cartridge technology together with novel nanomaterial-based plastic electrochemical biosensors. It provides results in 3 to 10 minutes or less.
To evaluate QDx InstaLab’s accuracy, the researchers performed each of its tests on 40 to 70 patient blood samples and compared the results with those of standard laboratory instruments. Through this, they found that the tests run on QDx InstaLab have a coefficient of variation < 3%, an R² value > 0.95, and an interference bias < 10%, which signifies that the QDX InstaLab is reliable and meets all the performance specifications of a lab.
Read more: First Lab-on-Cartridge Device That Can Perform All Common Medical Tests
The Latest on: Point-of-care testing devices
[google_news title=”” keyword=”Point-of-care testing devices” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Point-of-care testing devices
- Global Point of Care Molecular Diagnostics Industryon May 14, 2024 at 5:29 am
Global Point of Care Molecular Diagnostics Industry was estimated to be worth US$ 11.1 billion & likely to surge at a 9.7% CAGR By 2033 ...
- FDA Warns Against Use of Cue Health COVID-19 Testson May 13, 2024 at 12:40 pm
NEW YORK – The US Food and Drug Administration has issued a warning letter recommending against the use of Cue Health's COVID-19 tests for home, over-the-counter, and patient care use due to an ...
- Progress Report on Field Testing of Collecting Plastic Containers for Personal and Home Care Products Using a Local Government Collection Routeon May 13, 2024 at 9:58 am
Aiming to Reduce Costs and Secure Sufficient Material to Recycle - May 13, 2024 — From April 2023 to March 2024, Kao Corporation worked with ...
- Selecting the right motor for bench-top point-of-care testing deviceson May 7, 2024 at 9:14 pm
The importance of motion control Given the requirement for numerous applications of motion within a bench-top POCt device, from valve actuation to movement of the samples, miniature motor ...
- Roche Diagnostics India's Heart Failure Test for Diabetics Now Available on its Point-of-care Deviceon April 9, 2024 at 5:00 pm
Mumbai (Maharashtra) [India], April 10: Roche Diagnostics India announces the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of cardiovascular diseases ...
- AQURE point-of-care IT solutionon November 24, 2023 at 3:13 pm
A POC IT solution that connects people, devices and data. In your daily work of maintaining point-of-care testing (POCT) analyzers, operator access and compliance, a solution that keeps you at the ...
- Be Aware of False Glucose Results With Point-of-Care Testingon March 26, 2023 at 4:17 am
Include all staff who might perform blood glucose testing at the point-of-care. If involved products are used infrequently, a table posted in areas where insulin is prepared might be helpful.
- Point of Care Testing for Sexually Transmitted Infectionson January 8, 2023 at 10:17 am
What are sexually transmitted infections (STIs), and why do we care? What is point of care testing (POCT)? What do clinicians and patients want and need from the POCT for STIs? Point of care ...
- ICU point-of-care testing solutionon July 20, 2021 at 12:59 am
Point-of-care testing (POCT) offers excellent potential ... Efficient, powerful device-to-lab connectivity specially designed for the 24/7 management of POCT devices and operators.
- What is the window period for HIV testing?on December 14, 2020 at 7:39 pm
point-of-care tests and self-testing devices. Unfortunately, precise figures for how much longer the window periods are have not yet been published. NAM aidsmap's Matthew Hodson explains about window ...
via Bing News